Volume 17, Number 2—February 2011
Dispatch
Primary Amebic Meningoencephalitis Caused by Naegleria fowleri, Karachi, Pakistan
Table
Clinical features and CSF analysis results for 13 patients with Naegleria fowleri meningoencephalitis, Karachi, Pakistan, 2008–2009*
| Characteristic |
Patient nos., in order of treatment |
Descriptive statistics† |
||||||||||||
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
||
| Age, y | 31 | 25 | 30 | 36 | 60 | 30 | 64 | 18 | 22 | 16 | 18 | 18 | 35 | Mean 31.0 ± 15.33 |
| Date treatment sought | 2008 Jul | 2008 Sep | 2009 Apr | 2009 May | 2009 Jul | 2009 Jul | 2009 Jul | 2009 Jul | 2009 Aug | 2009 Aug | 2009 Oct | 2009 Oct | 2009 Nov | |
| Duration of illness before seeking treatment, d | 2 | 1 | 2 | 4 | 4 | 1 | 2 | 5 | 2 | 2 | 2 | 3 | 3 | Mean ± SD 2.5 ± 1.19 |
| Duration of survival after symptom onset, d |
6 |
15 |
3 |
6 |
7 |
9 |
7 |
6 |
5 |
3 |
3 |
7 |
6 |
Mean ± SD 6.38 ± 3.15 |
| Fever | + | + | + | + | + | + | + | + | + | + | + | + | + | Present in 13/13 (100%) |
| Headache | + | + | + | + | + | + | + | – | + | + | + | + | + | Present in 12/13 (92.3%) |
| Seizures |
+ |
– |
+ |
– |
+ |
– |
+ |
– |
+ |
+ |
+ |
+ |
– |
Present in 8/13 (61.5%) |
| CSF analysis | ||||||||||||||
| Glucose, mg/dL† | <5 | 42 | 2 | <5† | 26 | <5† | <5‡ | 30 | <5‡ | <5‡ | 80 | 50 | <5‡ | Undetectable in 53.8% |
| Protein, mg/dL | 1,028 | 418 | 909 | 774 | 504 | 1,147 | 1342 | 320 | 998 | 330 | 371 | 179 | 1,296 | Mean ± SD 739.69 ± 405.29 |
| Leukocytes, cells/mm3 | 900 | 900 | 5,976 | 2,000 | 2,500 | 7,500 | 5,200 | 6,000 | 840 | 6,500 | 150 | 185 | 11,750 | Mean ± SD 3,877.0 ± 3,565.37 |
| Neutrophils, % | 15 | 90 | 90 | 90 | 60 | 80 | 90 | 90 | 90 | 96 | 75 | 25 | 95 | Neutrophilic pleocytosis, 84.6 |
| Lymphocytes, % | 85 | 10 | 10 | 10 | 40 | 20 | 10 | 10 | 10 | 4 | 25 | 75 | 5 | Lymphocytic pleocytosis, 15.4 |
| CSF amebic culture | NA | + | + | + | + | + | + | + | + | + | + | + | + | NA |
| CSF PCR for N. fowleri | NA | NA | NA | NA | + | + | + | NA | NA | NA | NA | NA | NA | NA |
*All patients were male except patient no. 11, who was female. CSF, cerebrospinal fluid; +, present; NA, no data available.
†Statistics derived in SPSS software version 16.0 (LEAD Technologies, Charlotte, NC, USA).
‡Glucose <5 mg/dL= undetectable.


